What is Akkermansia muciniphila?
Akkermansia muciniphila is a bacterium naturally present in the human gut, where it helps maintain the mucus layer lining the intestine. It has become one of the more closely studied "next-generation" probiotics in recent years.
What does the research actually show?
A landmark human trial (Depommier et al.) found that supplementation with Akkermansia muciniphila improved insulin sensitivity and reduced markers associated with metabolic dysfunction over a 3-month period, in a small human cohort. This is real, published research — but it measured metabolic markers, not weight loss as a primary endpoint.
What it does NOT prove
The existing Akkermansia research was not designed or structured as a weight-loss trial. Marketing that frames Akkermansia as directly "burning fat" goes further than the published evidence supports.
Its role in SodaTide
Akkermansia muciniphila is part of SodaTide's 36mg three-strain probiotic blend. The blend's total weight is disclosed, though Akkermansia's specific individual amount is not broken out separately. See the full ingredients breakdown.
Safety considerations
Probiotics are generally well tolerated, but anyone with SIBO, a diagnosed GI condition, or immunosuppression should consult a doctor first.